JP7503310B2 - ヒノキチオール類似体、それらの調製方法及び医薬組成物 - Google Patents

ヒノキチオール類似体、それらの調製方法及び医薬組成物 Download PDF

Info

Publication number
JP7503310B2
JP7503310B2 JP2020554896A JP2020554896A JP7503310B2 JP 7503310 B2 JP7503310 B2 JP 7503310B2 JP 2020554896 A JP2020554896 A JP 2020554896A JP 2020554896 A JP2020554896 A JP 2020554896A JP 7503310 B2 JP7503310 B2 JP 7503310B2
Authority
JP
Japan
Prior art keywords
iron
hinokitiol
salt
compound
show
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2020554896A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021521116A (ja
JPWO2019200314A5 (https=
JP2021521116A5 (https=
Inventor
ディー バーク，マーティン
エス グリッロ，アンソニー
ジー チオフィ，アレクサンダー
サンタマリア，アナ
ブレア，ダニエル
ブレイク，アンドリュー
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Illinois System
Original Assignee
University of Illinois System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Illinois System filed Critical University of Illinois System
Publication of JP2021521116A publication Critical patent/JP2021521116A/ja
Publication of JPWO2019200314A5 publication Critical patent/JPWO2019200314A5/ja
Publication of JP2021521116A5 publication Critical patent/JP2021521116A5/ja
Application granted granted Critical
Publication of JP7503310B2 publication Critical patent/JP7503310B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/27—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
    • C07C45/29—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups
    • C07C45/292—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups with chromium derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J23/00—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
    • B01J23/38—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals
    • B01J23/40—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals of the platinum group metals
    • B01J23/44—Palladium
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/63—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of halogen; by substitution of halogen atoms by other halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/65—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by splitting-off hydrogen atoms or functional groups; by hydrogenolysis of functional groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/717—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups a keto group being part of a seven- to twelve-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/723—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic
    • C07C49/727—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic a keto group being part of a condensed ring system
    • C07C49/733—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic a keto group being part of a condensed ring system having two rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/753—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C61/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C61/16—Unsaturated compounds
    • C07C61/22—Unsaturated compounds having a carboxyl group bound to a six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/18—Systems containing only non-condensed rings with a ring being at least seven-membered

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Materials Engineering (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Catalysts (AREA)
JP2020554896A 2018-04-13 2019-04-12 ヒノキチオール類似体、それらの調製方法及び医薬組成物 Active JP7503310B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862657127P 2018-04-13 2018-04-13
US62/657,127 2018-04-13
PCT/US2019/027314 WO2019200314A2 (en) 2018-04-13 2019-04-12 Hinokitiol analogues, methods of preparing and pharmaceutical compositions thereof

Publications (4)

Publication Number Publication Date
JP2021521116A JP2021521116A (ja) 2021-08-26
JPWO2019200314A5 JPWO2019200314A5 (https=) 2022-04-15
JP2021521116A5 JP2021521116A5 (https=) 2022-04-15
JP7503310B2 true JP7503310B2 (ja) 2024-06-20

Family

ID=68163807

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020554896A Active JP7503310B2 (ja) 2018-04-13 2019-04-12 ヒノキチオール類似体、それらの調製方法及び医薬組成物

Country Status (8)

Country Link
US (1) US12084411B2 (https=)
EP (1) EP3773900A4 (https=)
JP (1) JP7503310B2 (https=)
KR (2) KR20260011772A (https=)
CN (1) CN112672786A (https=)
AU (2) AU2019252933B2 (https=)
CA (1) CA3095945A1 (https=)
WO (1) WO2019200314A2 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2019252933B2 (en) 2018-04-13 2025-09-04 The Board Of Trustees Of The University Of Illinois Hinokitiol analogues, methods of preparing and pharmaceutical compositions thereof
EP4045025A4 (en) * 2019-10-16 2023-11-22 Kinesid Therapeutics, Inc. TROPOLONE DERIVATIVES AND THEIR TAUTOMERS FOR IRON REGULATION IN ANIMALS
US20230406803A1 (en) * 2019-10-16 2023-12-21 Kinesid Therapeutics, Inc Tropolone derivatives and tautomers thereof for iron regulation in animals
CN114436909B (zh) * 2022-01-26 2023-05-30 河南科技大学 一种磺酰基桧木醇类衍生物及其制备方法和应用
CN115093356B (zh) * 2022-06-21 2024-02-23 广东医科大学 一种铁死亡诱导剂的制备方法与应用
JP2025531628A (ja) * 2022-09-30 2025-09-22 ザ ボード オブ トラスティーズ オブ ザ ユニヴァーシティ オブ イリノイ 神経変性疾患の処置方法
CN120282778A (zh) * 2022-09-30 2025-07-08 伊利诺伊大学评议会 氘化扁柏酚衍生物
CN117547525A (zh) * 2023-12-29 2024-02-13 中国科学院长春应用化学研究所 天然产物小分子桧木醇在制备治疗非酒精性脂肪性肝炎药物中的应用

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001089504A1 (fr) 2000-05-25 2001-11-29 Nippon Shinyaku Co., Ltd. Derives de tropolone et compositions pharmaceutiques
JP2004238291A (ja) 2003-02-03 2004-08-26 Osaka Organic Chem Ind Ltd 白血病細胞増殖阻害剤
JP2013237618A (ja) 2012-05-11 2013-11-28 Hinoki Shinyaku Kk サーチュイン１（ｓｉｒｔ１）遺伝子活性化剤
JP2015526396A (ja) 2012-06-22 2015-09-10 ユニバーシティ オブ コネチカット 置換トロポロン誘導体およびその使用方法
JP2018504392A (ja) 2015-01-09 2018-02-15 ザ ボード オブ トラスティーズ オブ ザ ユニヴァーシティ オブ イリノイＴｈｅ Ｂｏａｒｄ Ｏｆ Ｔｒｕｓｔｅｅｓ Ｏｆ Ｔｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｉｌｌｉｎｏｉｓ 小分子を用いた鉄欠乏生物における生理機能の回復

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4066784A (en) 1976-06-17 1978-01-03 Ayerst, Mckenna And Harrison Ltd. Tropone derivatives
US4183955A (en) 1976-06-17 1980-01-15 Ayerst. McKenna & Harrison Limited Troponyl-oxamic acid derivatives for treating allergic conditions
JP2552870B2 (ja) * 1986-08-21 1996-11-13 塩野義製薬株式会社 抗マイコプラズマ剤および抗マイコプラズマ活性を有する化合物
JP2622836B2 (ja) * 1987-02-04 1997-06-25 富士写真フイルム株式会社 メチン色素
JPH02237964A (ja) 1989-03-13 1990-09-20 Nippon Shokubai Kagaku Kogyo Co Ltd トロポロン誘導体
CN1247511C (zh) * 2000-12-26 2006-03-29 财团法人乙卯研究所 环庚三烯酚酮衍生物
US20100152301A1 (en) 2005-12-01 2010-06-17 Government Of The Us, As Represented By The Secretary, Department Of Health And Human Services Treatment of Viral Infections
JP2008158060A (ja) 2006-12-21 2008-07-10 Kyocera Mita Corp 電子写真感光体
WO2017156194A1 (en) 2016-03-08 2017-09-14 The Regents Of The University Of California Compositions and methods for inhibiting influenza rna polymerase pa endonuclease
US10980754B2 (en) * 2016-04-19 2021-04-20 Saint Louis University Anti-fungal compounds
AU2019252933B2 (en) 2018-04-13 2025-09-04 The Board Of Trustees Of The University Of Illinois Hinokitiol analogues, methods of preparing and pharmaceutical compositions thereof

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001089504A1 (fr) 2000-05-25 2001-11-29 Nippon Shinyaku Co., Ltd. Derives de tropolone et compositions pharmaceutiques
JP2004238291A (ja) 2003-02-03 2004-08-26 Osaka Organic Chem Ind Ltd 白血病細胞増殖阻害剤
JP2013237618A (ja) 2012-05-11 2013-11-28 Hinoki Shinyaku Kk サーチュイン１（ｓｉｒｔ１）遺伝子活性化剤
JP2015526396A (ja) 2012-06-22 2015-09-10 ユニバーシティ オブ コネチカット 置換トロポロン誘導体およびその使用方法
JP2018504392A (ja) 2015-01-09 2018-02-15 ザ ボード オブ トラスティーズ オブ ザ ユニヴァーシティ オブ イリノイＴｈｅ Ｂｏａｒｄ Ｏｆ Ｔｒｕｓｔｅｅｓ Ｏｆ Ｔｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｉｌｌｉｎｏｉｓ 小分子を用いた鉄欠乏生物における生理機能の回復

Also Published As

Publication number Publication date
JP2021521116A (ja) 2021-08-26
AU2019252933B2 (en) 2025-09-04
KR20210020876A (ko) 2021-02-24
EP3773900A2 (en) 2021-02-17
US20210163393A1 (en) 2021-06-03
CA3095945A1 (en) 2019-10-17
WO2019200314A2 (en) 2019-10-17
WO2019200314A3 (en) 2019-11-21
AU2025220735A1 (en) 2025-09-11
CN112672786A (zh) 2021-04-16
US12084411B2 (en) 2024-09-10
EP3773900A4 (en) 2022-03-30
KR102907811B1 (ko) 2026-01-02
AU2019252933A1 (en) 2020-11-26
KR20260011772A (ko) 2026-01-23

Similar Documents

Publication Publication Date Title
JP7503310B2 (ja) ヒノキチオール類似体、それらの調製方法及び医薬組成物
CN105051015B (zh) 吡唑-酰胺化合物和其医药用途
US11426402B2 (en) IRE1 activating compounds for use in therapy
Edison et al. Iron homeostasis: new players, newer insights
EP3348557B1 (en) Imidazo[1,2a]pyridines for treating or preventing hyperuricemia or gout
TW201536748A (zh) 茀－醯胺化合物及其醫藥用途
Salehi et al. Synthesis, characterization and in vitro anticancer evaluations of two novel derivatives of deferasirox iron chelator
JP7613743B2 (ja) 転移性癌および化学療法抵抗性癌の治療のためのテトラヒドロキノリノ誘導体
AU2016220153A1 (en) Therapeutic compounds
KR101640512B1 (ko) 안드로겐 수용체의 소분자 억제제
KR102329486B1 (ko) 할로겐화 화합물 및 이의 축상 키랄성 이성질체
JP6571688B2 (ja) 置換アセチドラジド誘導体、その調製方法及び使用
US20120071505A1 (en) Substituted pyridine derivatives, pharmaceutical compositions, and methods of use to treat oxidative stress
EP3305293A1 (en) Method for treating or preventing diabetic nephropathy
EP4613274A1 (en) Senolytic compounds
US20240043372A1 (en) Substituted aromatic compounds and pharmaceutical compositions thereof
EP4248959A1 (en) Preparation for reduction of pathological iron overload
CN118598850A (zh) 靶向降解hoip蛋白化合物、包含其的组合物及应用
WO2024245370A1 (zh) 一种组合产品、盐及其用途
CN1332921C (zh) 治疗心脏和代谢紊乱的主环取代的甲状腺受体拮抗物
HK40049062A (en) Tetrahydroquinolino derivatives for the treatment of metastatic and chemoresistant cancers
NZ712292B2 (en) Pyrazole-amide compound and medicinal uses therefor

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210106

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220407

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20220407

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20230316

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230406

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20230626

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230904

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20231127

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240226

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20240502

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20240603

R150 Certificate of patent or registration of utility model

Ref document number: 7503310

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150